Announcements

2 May 2024
MDPI Insights: The CEO's Letter #11 - 2023 Annual Report, MDPI Awards, STM

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

2023 Annual Report

This is an exciting time of year at MDPI, as we have just released our annual report 2023, recapping the past year and sharing the progress and changes that took place during it.


Stefan Tochev (CEO, MDPI)

Reflecting on 2023, I can't help but think of the changes that have occurred not only at MDPI but also within our industry as a whole. In light of this, I’m reminded that change is the only constant, and that for a publishing enterprise that has experienced rapid growth, adapting to change becomes not only a necessity but also a catalyst for sustained success.

Looking back on the significant ground we covered in 2023, I am pleased to report that the year was marked by a rise in paper submissions, along with a range of initiatives aimed at improving our internal processes and delivering top services to our scientists.

2023 Top-line MDPI Numbers

An important priority for 2023 was to strengthen our editorial policies. Despite a notable increase in the number of papers submitted from 603,000 to 655,000 (+8.6%), there was a decrease in the number of papers published from 303,000 to 285,000 (-5.9%), consistent with the overall trend in the scholarly publishing market. MDPI’s market share in gold open access articles published reached 17% in 2023 (according to Dimensions data).

2023 Open Access Numbers

For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment to, and vision for, an open future. This momentum continued in 2023, with 39% of the 4.16 million articles and reviews published as gold full-OA, 15% as gold hybrid-OA, 8% as bronze-OA, and 3% as green-OA, relative to 35% behind a paywall. In terms of gold OA (full or hybrid) articles and reviews published, MDPI leads the way in terms of total articles published in 2023.

MDPI is the trusted and preferred OA publisher for the scholarly community

However, in 2023, we saw a downward trend in publication numbers compared to 2022. This trend was also seen in total OA publications. While the number of submissions increased, the decline in MDPI publications can be attributed to several factors, such as improved scrutiny in our peer-review process, including the evaluation of content scope and higher rejection rates, and a post-pandemic decrease in research related to COVID-19 papers.

Download 2023 MDPI Annual Report.
Access 2023 Digital Report.

Impactful Research

Recognizing Scholars – MDPI Awards

MDPI is committed to empowering young researchers as they embark on their careers. In 2023, our journals hosted a total of 400 awards, receiving 8,839 applications and nominations. The evaluation committees selected 959 winners, with the total budget for these awards amounting to CHF 546,500.

For more information about MDPI awards, applications, and winners, please click here

The following awards recognize scholars and the impact of their research, including Young Investigator Awards, Best PhD Thesis Awards, and Travel Awards for junior researchers.

MDPI Awards – The following awards require an application or a nomination.

Young Investigator Award (CHF 1000–2000 for each winner)
This award acknowledges the achievements of young investigators in research areas relevant to the journal’s scope. Candidates must have received their PhD no more than 10 years prior to the award announcement date and must be nominated.

Best PhD Thesis Award (CHF 500–800 for each winner)
This award recognizes young scholars who have completed outstanding PhD theses in research areas relevant to the journal’s scope. It aims to encourage them to continue their excellent work and make further contributions to their field.

Travel Award (CHF 500–800 for each winner)
This award encourages junior scientists to present their latest research at academic conferences relevant to the journal’s scope, thereby increasing their impact.

Distinguished Scholars
Additionally, 220 awards were granted to the most distinguished authors and reviewers in our journals through Best Paper Awards and Outstanding Reviewer Awards. The following awards are selected by the editorial staff of the journal and do not require an application or a nomination. They exemplify the excellent contributions made by our authors, reviewers, and editors.

These awards exemplify the excellent contributions made by our authors, reviewers, and editors

Best Paper Award (CHF 200–500 for each winner)
This award is granted annually to highlight publications of high quality, scientific significance, and extensive influence.

Outstanding Reviewer Award (CHF 500 for partial winners)
This award is given annually to recognize reviewers who generously contribute their time to reviewing papers and demonstrate thoroughness, professionalism, and timeliness in their reviews.

MDPI also offers awards for specific topics in various research fields:

Carbon Neutrality Award (CHF 500–800 for each winner)
Sponsored by MDPI journal Sustainability, this award recognizes applicants who have made exceptional academic or societal contributions to carbon neutrality, either in general or in relation to a specific carbon-neutrality-related issue.

Intelligent Manufacturing Award (CHF 500–800 for each winner)
Administered by MDPI journal Machines, this award is presented to an individual who has made outstanding academic or societal contributions to the field of intelligent manufacturing.

Granted: World Sustainability Awards

Inside MDPI

MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

As CEO of the world’s leading OA publisher, I am pleased to announce the official opening of our Korean branch office. With this addition, MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher. This expansion represents more than just an increase in our physical footprint; it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible across the globe.

MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher


Claude Seo (MDPI Korea Office Manager, Seoul)

Claude Seo, who has over 15 years of experience in the academic publishing industry, has been appointed as the Office Manager of the Seoul office. The launch of our Seoul office allows us to better support the Korean scientific community and to further promote the publication of OA journals in the region.

Reflecting on his role, Claude shared that he is:

“Delighted to have been entrusted with this position within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating ourselves into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

Additionally, I am pleased to share that Sungkyunkwan University has joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDP’s online submission system for institutions and provides APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyunghee University, Chung-Ang University, and the Catholic University of Korea, have adopted IOAP in Korea.

Learn more about MDPI’s collaboration in Korea in my previous CEO Letter, in which I recap our visit to Seoul, South Korea.

Coming Together for Science

4th MMCS: Harnessing the Power of New Drug Modalities

Our conference team successfully managed the 4th Molecules Medicinal Chemistry Symposium, held from 24–26 April in Barcelona, Spain. It was chaired by Prof. Dr. Diego Muñoz-Torrero from the Institute of Biomedicine (IBUB), University of Barcelona, Spain, and Prof. Dr. Simona Collina from the University of Pavia, Italy. In total, there were 84 accepted abstracts and 102 conference attendees from 22 different countries.


From left to right: Prof. Dr. Rino Ragno (Scientific Committee), Dr. Maria Emilia Sousa (Scientific Committee), Prof. Dr. Claudio Viegas Jr. (Scientific Committee), Prof. Dr. Simona Collina (Chair), Prof. Dr. Diego Muñoz-Torrero (Chair), Alvina Wu (Managing Editor, MDPI), Prof. Dr. Roman Dembinski (Scientific Committee), Prof. Dr. Mariana Spetea (Scientific Committee).

The event comprised 12 Invited Speakers, 35 Selected Talks, 10 Flash Poster Presentations, and 39 Posters. The overarching topic of the conference was the impact of the emergence of new drug modalities on drug discovery, with thematic sessions covering topics such as photoactivatable drugs, candidates targeting RNA and epigenetic targets, covalent modifiers, and the development of new anti-cancer agents, among other medicinal chemistry projects.

We are pleased to have received feedback from attendees highlighting the professional approach of the conference chairs and participants, the high quality of the talks, and the overall outstanding organization on the part of the MDPI conference team.

Thank you to the conference sponsors, Fluorochem and IBUB, and to our partnering societies, The Spanish Society for Biochemistry and Molecular Biology (SEBBM), and the Spanish Society of Medicinal Chemistry (SEQT).

Upcoming In-Person Event

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
Conference Chairs: Prof. Dr. Dimitrios Bikiaris, Prof. Dr. Konstantinos Triantafyllidis, Dr. Ioanna Deligkiozi
We look forward to welcoming experts Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.

Find more upcoming MDPI events here.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

A Report from the Future – STM US Annual Conference 2024


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board.

MDPI has for a long time been a sponsor of the STM Annual Conferences, held yearly in the US and Frankfurt, and is a trusted partner and supporter of the STM organization. While I have attended the Frankfurt conference for the past three years, this was my first time visiting the Washington, DC session, and I am glad I did.

Although it was a brief trip, I greatly appreciated the opportunity to attend in the company of my colleagues Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board. They always help map some of the new industry trends against MDPI’s operational framework and guidelines. It’s a great group for kicking ideas back and forth on what we can apply at MDPI.

In my experience, STM never fails to deliver. It’s always a great conference for reconnecting with fellow publishers, industry friends, and vendors. As usual, STM this year curated a diverse range of speakers and panels, who proferred valuable knowledge and insights from outside our industry, delivering thought-provoking insights into our field. An example of this was the ‘Trust Panel’ session, which included Alan Schiffres (Managing Director, InfoLinx), who shared a number of the learnings about fraud and risk management from his 40 years in financial services, to help address some of the challenges we are currently facing in the area of publishing integrity.

Launch of STM Trends 2028 Panel

I particularly enjoyed the ‘Launch of STM Trends 2028 Panel’, which presented a report focused on the integration of humans and machines in scholarly publishing. The session highlighted themes such as AI, digitization, and the evolving research ecosystem. The report envisions a future where technology blurs the lines between human and machine involvement in research processes, with significant implications for trust, reputation, and equity. While this presents opportunities for connectivity and knowledge dissemination, it also poses challenges such as disinformation, fragmentation, and geopolitical tensions. We must rely on a wise combination of technology and human agency to navigate this complex landscape and will have to carefully examine its potential impacts on communication and scholarly publishing.

MDPI has joined the STM Integrity Hub. Click here to learn more.

While every presenter brought their own knowledge and personal touch, I was particularly pleased to encounter new speakers such as Heather Whitney (Research Assistant Professor, Radiology, University of Chicago) and Igor Grossmann (Professor of Psychology, University of Waterloo, Canada). Having studied Sociology at the University of Guelph, I have a soft spot for fellow social scientists from Canada, and I was very impressed by Igor’s presentation on ‘The Social Scientist: A View from the Future’ and his participation in the panel session ‘The Future Beyond the Article,’ which was one of my favourites from the conference, given the diversity of perspectives from the panel speakers.

Memorial Park in Washington, DC

On a personal note, this was my first-time visiting Washington, DC, and I’m glad we took an afternoon to visit the Memorial Park, with its incredible monuments to figures ranging from Martin Luther King, Jr. to Abraham Lincoln. The magnitude of the monuments is deeply impressive. I particularly appreciated the Thomas Jefferson memorial and the following quote, which I think speaks to the importance of change and adaptation. It’s something we can apply not only in our industry but also in our personal lives.

"I am not an advocate for frequent changes in laws and constitutions, but laws and institutions must go hand in hand with the progress of the human mind. As that becomes more developed, more enlightened, as new discoveries are made, new truths discovered and manners and opinions change, with the change of circumstances, institutions must advance also to keep pace with the times. We might as well require a man to wear still the coat which fitted him when a boy as a civilized society to remain ever under the regimen of their barbarous ancestors."

– Excerpted from a letter to Samuel Kercheval, July 12, 1816.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 April 2024
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

MDPI, the leading Open Access (OA) publisher, announced on Monday that it opened its Korean branch office on 29th April 2024. With this addition, MDPI now operates 21 offices in 12 countries worldwide. Claude Seo, with over 20 years of experience in the academic journal publishing industry, including Nature Publishing Group (NPG), has been appointed as the Office Manager of the Seoul office.

With the establishment of a Seoul office, MDPI aims to actively support Korea scientific communities to further promote the publication of OA journals in the region. As of the end of 2023, Korea ranked sixth worldwide in both submissions and publications of MDPI research papers. MDPI is the number one OA publisher in Korea.


Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

In addition, MDPI announced that Sungkyunkwan University joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDPI online submission system for the institutions and APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyung Hee University, Chung-Ang University and Catholic University of Korea, have adopted IOAP in Korea.

OA aims to break down barriers that have traditionally restricted access to science, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Authors, academia, and scientific communities are rapidly moving toward OA. MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020.


MDPI CEO Visits Seoul, Korea

In March, Stefan Tochev, Chief Executive Officer (CEO) of MDPI, visited Korea and met with various stakeholders including government agencies, research and academic institutions, universities. During his visit, Stefan highlighted that MDPI continues to pave the way for a world where science is accessible to all, supporting a global community of inclusive innovation and collaborative solutions.

Stefan expressed excitement about the new venture, stating, "Today marks a significant milestone for MDPI as we celebrate the opening of our new office in Seoul, Korea. This expansion is more than just an increase in our physical footprint, it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible, participatory, and inclusive across the globe."

Claude Seo, reflecting on his new role, commented, "I am delighted to have been offered this position of trust within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

For further inquiries, please contact our Seoul office directly.


About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.3 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 diligent, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully OA titles.

10 April 2024
Meet Us at the 48th FEBS Congress, 29 June–3 July 2024, Milan, Italy


Conference:
The 48th FEBS Congress
Date: 29 June–3 July 2024
Location: Milan, Italy

MDPI will be attending the 48th FEBS Congress at Booth #30, and we welcome researchers from different backgrounds to visit us and share their latest ideas.

The Italian Society of Biochemistry and Molecular Biology (SIB), founded in 1951, will host the event. The 48th FEBS Congress—“Mining biochemistry for human health and well-being”—welcomes scientists from Europe and other parts of the world.

The 48th FEBS Congress will present a broad-spectrum and ground-breaking scientific program in a fruitful collaboration with FEBS journals and representatives from FEBS Constituent Societies. The SIB and biochemical community are focusing on human health and well-being through molecular and cellular science approaches; this is a key social issue amid ongoing global transitions. Besides presenting the latest and emerging developments in biochemical sciences, the Congress will include dedicated education-oriented sessions, symposia organized by young biochemists, and biochemistry-related economic discussions. Industry representatives will also give presentations on the latest advances in commercial instrumentation.

The following MDPI journals will be represented:

If you plan to attend this conference, please start an online conversation with us. Our delegates look forward to meeting you in person and answering your questions. For more information about the conference, please visit the following website: https://2024.febscongress.org/.

2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.

Visit to Seoul, South Korea

During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).

As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.

MDPI and South Korea by Numbers

As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.

“South Korea is the sixth-largest contributor to our total publications”

Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.

Institutional Partnerships with South Korea

I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.

Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.

MDPI Hosts Seminar for Academia and Media

As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.

“MDPI is actively democratizing science”

MDPI in the News


Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.

Media coverage generated by our visit to Seoul included the following stories:

“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”

“Papers that the public needs, anyone can use quickly… low-quality publishing is a misunderstanding.”

I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.

Impactful Research

Featured Articles on Women’s Leadership and Healthcare

In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.

Women’s Leadership

Women’s Reproductive Health

Women’s Preventive Healthcare

Featured Articles in MDPI Journal Women

Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.

Inside MDPI

 

Championing Women’s Healthcare and Access to Healthcare Information

MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:

  • Empowering women to assume leadership and decision-making roles in both business and science.
  • Helping women and girls make informed decisions about their health.
  • Recruiting and developing female talent and fostering inclusive workplace environments.

“We are thrilled to recognize the accomplishments of women scientists”

I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.

We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.

“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’

“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’

Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.

Coming Together for Science

MDPI Joins United2Act in Collective Fight to Stop Paper Mills

In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.

The text below is taken from our official announcement:

United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.

Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.

MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.

United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:

  • Education and awareness
  • Improve post-publication corrections
  • Facilitate and organise research on paper mills
  • Enable the development of trust markers
  • Facilitate dialogue between stakeholders

MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.

Closing Thoughts


Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.

Visit to Tokyo and Kyoto, Japan

In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.

We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.

Japan’s Open Access statistics

Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:

  • 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
  • 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
  • 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.

To learn more about the history of OA in Japan as well as about future trends, please read this blog post.

“Japan is the ninth-largest contributor to our total publications”


Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.

MDPI and Japan by Numbers

As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.

In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.

General Feedback – a side note

A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.

That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.

Stefan Tochev
Chief Executive Officer
MDPI AG

29 March 2024
Meet Us at the 20th Annual International Conference of the Metabolomics Society (Metabolomics 2024), 16–20 June 2024, Osaka, Japan


MDPI will be attending the 20th Annual International Conference of the Metabolomics Society (Metabolomics 2024) held in Osaka, Japan, from 16 to 20 June 2024. The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. This is the third time that the conference will be held in Japan, following the 2005 and 2014 conferences held in Tsuruoka. We look forward to welcoming the metabolomics community, building strong connections, and discussing world-class research in a relaxed collegial environment. Let us build on the momentum of the incredible Niagara Falls and Valencia conferences that brought us back together in person, and make it the best meeting of 2024 together!

During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest views and research with us.

The following MDPI journals will be represented:

  • Metabolites;
  • Biomolecules;
  • Plants;
  • IJMS;
  • Life;
  • Cells;
  • Agronomy;
  • Nutrients;
  • Cancers;
  • CIMB;
  • Genes;
  • Antioxidants.

If you plan on attending this conference, feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit the following link: https://www.metabolomics2024.org/.

26 March 2024
Antioxidants Selected as a High-Quality Scientific Journal

The China Association for Science and Technology has been compiling and publishing high-quality journal hierarchical catalogs for domestic and foreign scientific journals in subject areas, providing reference for scientific workers to publish papers and for scientific research institutions to conduct academic evaluations since 2019. This evaluation aims to implement the “Opinions on Deepening Reform and Cultivating World-Class Scientific and Technological Journals”, promote the establishment of an evaluation guide for domestic and foreign journals that are of the same quality and equivalence, and guide more high-level results to be published in domestic journals.

We are pleased to announce that Antioxidants (ISSN: 2076-3921) was selected as a high-quality scientific journal in the food science and engineering field.

Antioxidants ranks as follows: 

  • Q1 (13 out of 124 journals) in the “Food Science & Technology” category;
  • Q1 (6 out of 60 journals) in the “Chemistry, Medical” category;
  • Q1 (46 out of 285 journals) in the “Biochemistry & Molecular Biology” category.

For more journal statistics, please visit the following link: https://www.mdpi.com/journal/antioxidants/stats.

The Antioxidants Editorial Office would like to thank all the authors, reviewers, and editors who have contributed to the journal.

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 January 2024
New Drug That Improves Survival in People with Advanced Brain Cancer Created by Prof. Dr. Ines Batinic-Haberle, Editorial Board Member of Antioxidants

We are pleased to announce that our Editorial Board Member, Prof. Dr. Ines Batinic-Haberle from Duke University School of Medicine, USA, created a new drug called BMX-001, which improved survival and lessened cognitive decline for people with advanced brain cancer (high-grade glioma) enrolled in a phase 2 clinical trial. The drug is also under study in clinical trials for several other cancers. 

BMX-001 mimics the action of an enzyme made naturally by the body called superoxide dismutase, which was discovered in the 1960s by Irwin Fridovich, Ph.D., a Duke biochemist who was internationally renowned as “the father of free radical biology”. 

Free radicals are unstable forms of oxygen that can damage cells. Dr. Fridovich discovered that superoxide dismutase neutralizes free radicals, and thus, it is “the enzyme that we cannot live without”, Prof. Dr. Batinic-Haberle said.

You can learn more about the new drug at the following link: https://medschool.duke.edu/news/drug-born-duke-improves-survival-people-advanced-brain-cancer.

Let us congratulate Prof. Dr. Ines Batinic-Haberle on her success and new achievement.

30 January 2024
Acknowledgment of the Reviewers of Antioxidants in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Antioxidants. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Antioxidants received 7784 review reports, from 4408 reviewers. This past year, we worked with reviewers from 57 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Antioxidants family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

A Ganesan Katarzyna Otulak
Abdel Ali Belaidi Katarzyna Pawińska-Wąsikowska
Abdul Rashid Aziz Katarzyna Piotrowska
Abhishek Jha Katarzyna Pobiega
Abraham Wall-Medrano Katarzyna Sosnowska
Adam Jurgoński Katarzyna Sułkowska-Ziaja
Adela Pintea Katarzyna Zorena
Adele Papetti Katerina Chlichlia
Adelina Vlad Katherine Wall
Adham Al-Sagheer Katsuhito Kino
Adina Magdalena Musuc Katsuyuki Tanabe
Aditya Joshi Kay-Dietrich Wagner
Adrian Man Kazuhiko Nakadate
Agata Bartyzel Kazuto Tajiri
Agata Szłapa-Kula Keiichi Matsubara
Agnese Po Keisuke Ishizawa
Agnieszka Szczepek Ken Shirato
Agnieszka Szewczyk Kenji Saitoh
Agnieszka Szlagatys-Sidorkiewicz Kenneth N. White
Agnieszka Zdzislawa Robaszkiewicz Khalid Haddi
Agustin Ariño Kimberley Wang
Ahmed El Ghorab Kirk Anderson
Aida Moreira Da Silva Kishor Pant
Aimee Eggler Kiyoshi Fujisawa
Akalesh Verma Klaus Groschner
Akihito Tsubota Klaus Holzmann
Akira Obana Konrad Szychowski
Akylbek Sydykov Konstantin Chegaev
Albert Morales Konstantin Volcho
Alberto Gianinetti Konstantinos Kasiotis
Alberto Rodriguez-Archilla Konstantinos Papanikolaou
Albino Carrizzo Koya Yamashiro
Albrecht Piiper Krishnan Sriram
Aldona Siennicka Kristina Kantminienė
Alejandra García-Gasca Kristina Sharlo
Alejandro Ferrando Krzysztof Dwiecki
Alejandro Tapia Krzysztof Zborowski
Aleksander Tworak Kui Zhang
Aleksandra Czumaj Ky Park
Aleksandra Duda Kyle Poulsen
Alessandra Altomare Laima Česonienė
Alessandra Colciago Lakshmaiah Sreerama
Alessandra Ferramosca Lara Manyes
Alessandro Maugeri László Orlóci
Alessia Remigante László Vécsei
Alessio D'Alessio Laura A. De La Rosa
Alexa Klettner Laura Bardi
Alexander Baykov Laura Bulgariu
Alexander Dvoretsky Laura Carolina Zanetti-Domingues
Alexander Goroncy Laura Giuseppina Di Pasqua
Alexander Ivanov Laura López-Pingarrón
Alexander Lukatkin Laura Orian
Alexander Shtil Laura Sabatino
Alexander Surin Laura Vicente
Alexandr Mikyška Laurent Dufossé
Alexandra Lappas Laurentiu M. Pop
Alexei Medvedev Lavinia-Florina Calinoiu
Alexios Vlamis Leire Pedrosa
Alfredo Aires Lentze Michael
Alica Pizent Leonel Pereira
Alice Verticchio Vercellin Leonid Bystrykh
Alla Ivanova Leszek Tylicki
Alma Alarcon-Rojo Leticia Xochitl López Martínez
Alvaro Hermida Letizia Bernardo
Amanda Laca Leto-Aikaterini Tziveleka
Amelia Silva Li Fu
Amit Jaiswal Li Liang
Amritlal Mandal Lia Mara Diţu
Ana Carolina Gonçalves Liang Chen
Ana González-Paramás Lia-Tânia Dinis
Ana Jurinjak Tusek Libor Vitek
Ana Lúcia Ferreira Licinia L. G. Justino
Ana Mornar Lídia Gonçalves
Ana Pereira Liliya Nikitina
Ana Rey Lilya Dzhemileva
Ana Sayago Lina Cossignani
Anabel Lostao Lina Raudone
Anaberta Cardador-Martínez Lin-Fu Liang
Anbazhagan Sathiyaseelan Ling Yang
Anca Toiu Lingli Deng
André Lechel Lionel Ulmann
Andrea Baschieri Lisardo Boscá
Andrea Battistoni Livius D'Uscio
Andrea Mastinu Lmansour Mansour
Andrea Ragusa Loredana Bergandi
Andrea Sevcovicova Lorena Duca
Andreas Brodehl Lorenzo Nissen
Andreas Koschella Loris Pinto
Andreas Meyer Lothar Brecker
Andreas Simm Lubomir Lapcik
Andrei Khlebnikov Luca Forti
Andrei Vasile Nastuta Luca Vanella
Andreia Carvalho Lucia Baldino
Andreia Rodrigues Lucia Marcocci
Andrey Poddel'sky Lucian Birsa
Andrzej Szutowicz Lucian Copolovici
Andy T. Y. Lau Lucian Hritcu
Anelia Iantcheva Luciana Baroni
Aneta Ostróżka-Cieślik Luciana Bordin
Ang Li Lucjusz Zaprutko
Angel Josabad Alonso-Castro Ludmila Kazdova
Angel Llamas Luigi Menghini
Ángel Luis García-Otín Luís Barbisan
Angela Bisio Luís Félix
Angela Sorrentino Luis Medina-Juárez
Angélica Villarruel-López Luis Noguera-Artiaga
Angeliki Katsafadou Łukasz Szeleszczuk
Anika Wagner Łukasz Zielonka
Anita Kloss-Brandstätter Lyudmila Bel'Skaya
Ann Anderson Berry Maciej Socha
Anna Baldisserotto Mack Shelley
Anna Bilska-Wilkosz Magdalena Kotańska
Anna Bizoń Magdalena Martinez-Cañamero
Anna Giusti Magdalena Mizerska-Kowalska
Anna Gramza-Michalowska Magdalena Wróbel-Kwiatkowska
Anna Kabłak-Ziembicka Mahmoud Azzam
Anna Lewinska Maik Jacob
Anna Oniszczuk Maja Jazvinšćak Jembrek
Anna Rudawska Malcolm Jobling
Anna Szakiel Małgorzata Gniewosz
Anna Vittoria Mattioli Małgorzata Grabarczyk
Anna Wiktorowska-Owczarek Małgorzata Materska
Annalisa Chiavaroli Małgorzata Olszowy-Tomczyk
Annalisa Maietti Małgorzata Przybyło
Annamaria Passantino Małgorzata Szczuko
Annette Graham Man Qu
Antimo Di Maro Manuel Gómez-Guzmán
Anton Petcherski Manuel Mazo Vega
Anton Terasmaa Manuel Viuda-Martos
Antonella Costantini Mara Marongiu
Antonella D'Anneo Marc Herb
Antonella Di Sotto Marcela-Elisabeta Barbinta-Patrascu
Antonella Maria Aresta Marcello Pinti
Antonella Pasqualone Marcelo Barros
Antonella Rosa Marcelo Muscara
Antonella Smeriglio Marcia Helena Siegel
Antoni Pons Marcin Lukasiewicz
Antonieta Ruiz Marcin Łukaszewicz
Antonietta Gerarda Gravina Marco Alves
Antonio Alfonzo Marco Carmignani
Antonio Barbato Marco Catto
Antonio Gonzalez-Casado Marco Cosentino
António Manuel Jordão Marco Nunez
Antonio Mincione Marco Orecchioni
Antonio Orlacchio Marco Pietrella
Antonio Salatino Marco Poiana
Antonio Vassallo Marcos Lima
Arabela Untea Marcus Mareel
Arianna Scuteri Marek Murias
Aris Giannakas Marek Pieszka
Arkadiusz Lubas Marek Wesolowski
Arkadiusz Nędzarek Margarida Duarte-Araújo
Armando Caseiro Margarita Apostolova
Armida Sanchez-Escalante Margherita Eufemi
Arno Christian Gutleb Margherita Neri
Aron Nemeth Maria A. Bonifacio
Arrigo Cicero Maria Angeles Rojo
Artur Ratkiewicz Maria Antonietta Panaro
Artur Ribeiro Maria Carmela Bonaccorsi Di Patti
Arunava Ghosh María Concepción Robles-Gil
Asta Judzentiene Maria Concetta Geloso
Asunción Amorós Maria De Lurdes Nunes Enes Dapkevicius
Atefeh Najafi María Del Carmen Sánchez Beltrán
Athanasios C. Kimbaris Maria Del Pilar Carrera-González
Athanasios Papakyriakou Maria Elena Giordano
Augustin C. Moţ Maria G. Detsika
Auriel A. Willette Maria Garcia-Fernandez
Avi Shpigelman Maria Gazouli
Barbara Lapinska Maria Giovanna Scioli
Bart Van Hoek Maria Grazia Cerrito
Bartlomiej Krazinski María I. Rodríguez-López
Bartosz Jan Płachno Maria Isabella Sifola
Beata Druzynska Maria Leonor Faleiro
Beata Modzelewska María Luisa Ojeda Murillo
Beata Morak-Młodawska María Luisa Soto-Montenegro
Beatrice Macchi Maria Mola
Benoît Chénais Maria Montserrat Rivera Del Álamo
Bernd Kaina María Pérez-Fernández
Bernd Moosmann Maria Pia Ferraz
Bice Avallone Maria Russo
Bimal Chitrakar Maria S. Muntyan
Bingxian Xie Maria Simona Chis
Bo Zhou María Teresa Llinas Más
Bogna Grygiel-Górniak Marialucia Gallorini
Bogumila Pilarczyk Mariana Floria
Boguslawa Luzak Mariana Palage
Bogusz Kulawiak Mariana Petkova
Boldeanu Virgil Marianna Patrauchan
Boleslaw T. Karwowski Mariano Francesco Caratozzolo
Boris Krasnikov Mariapia Rigobello
Branka Salopek Sondi Maribel Acién
Brendan Duggan Marieta Constantin
Brindusa Tiperciuc Marija Gizdavic-Nikolaidis
Bruno Sousa Marina Piscopo
Carla Perego Marina Sagnou
Carlo Corino Marina Villalon-Mir
Carlo Mischiati Marino Paroli
Carlos Alvarez-González Mario Ščetar
Carlos Escobar Marioara Avram
Carlos Gravato Mariola Kozłowska
Carlos López-De-Celis Marios Spanakis
Carlos Sanz Mariusz Hartman
Carlos Vasconcelos Mariusz Siemiński
Carlota Gómez-Rincón Marjorie Jones
Carmela Barone Mark Borja
Carmen Del Toro Sánchez Mark Willems
Carol Johnston Marloes Dekker Nitert
Carsten Theiss Marta Grodzik
Catello Di Martino Marta Igual
Catherine Bennetau-Pelissero Marta Laranjo
Catherine Yzydorczyk Marta Martinez-Julvez
Cátia Ramalhete Marta Riera
Chang Chen Martin Cerny
Chang Wei Hsieh Martin Gierus
Changkeun Kang Martin Kello
Chao Qi Martin Raspor
Chao Wang Martin Schepelmann
Chaohui Feng Martina Smolic
Charalampos Proestos Mary Taub
Charles Norton Marzena Sujkowska-Rybkowska
Charlie Rice Marzia Di Donato
Chia-Che Chang Masaaki Kurasaki
Chiara Calabrese Masako Toda
Chiara Foglieni Masami Yoshimura
Chiara Maria Motta Masayuki Fujita
Chien-Chung Yang Massimiliano Errico
Chih-Li Lin Massimo Bertinaria
Chii-Ming Lee Massimo D'Archivio
Choon Young Kim Mats Eriksson
Christian Barbato Mats Troedsson
Christian Lehmann Matthias Eckhardt
Christina Banti Matti Jauhiainen
Christine Curcio Mauricio Antonio Retamal
Christine Winterbourn Maurizio Badiani
Christoph Hudemann Maurizio Crestani
Christos Pappas Maurizio Mulas
Chrysanthos Maraveas Mauro Lombardo
Chrysoula Voidarou Maximilian Deußing
Chung-Hsin Wu Melanie Ricke-Hoch
Chung-Ming Chen Melissa Burmeister
Chunki Fong Melissa Fath
Cinzia Fabrizi Mengxi Shen
Claire M. Kelly Meral Yuksel
Claudio Cantini Mercedes Fernandez
Claudio Caprari Mi Kyung Park
Claudio Ferrante Michael Barnes
Concepció Amat Michael Morris
Concettina La Motta Michael Petrie
Cong Wang Michael Poteser
Constantinos Giaginis Michael Schirmer
Cornelia Mircea Michael Shestopalov
Corneliu Tanase Michael Weller
Cosmas Nathanailides Michel Puceat
Costantino Balestra Michela Ferrucci
Cristina Banfi Michela Verni
Cristina Gabriela Grigoraş Mieszko Wieckiewicz
Cristina Manuela Dragoi Miguel Brito
Cristina Mas-Bargues Miguel García-Castro
Cristina Prieto Miguel Romero
Cristina Sgherri Mihaela Skrt
Cristina Vassalle Mikhail Kostik
Csengele Barta Mikhail Vorob'ev
Cyril Nicolas Mikko Laukkanen
Dae-Wui Yoon Milan Houška
Daisuke Seo Min Gi Jo
Damiano Tanini Ming-Ju Hsieh
Damien Arnoult Ming-Wei Lin
Danial Roshandel Miquéias Lopes-Pacheco
Daniel Barbosa Miquel Mulero
Daniel Liedtke Mircea Nicoara
Daniel Ortuño-Sahagún Mirela Kopjar
Daniel Potaczek Mirella Nardini
Daniela Buchaim Miriam Hickey
Daniela Elena Serban Mirosław Anioł
Daniela Hanganu Mirosław Wyszkowski
Daniela Iancu Mititelu Magdalena
Daniela Opriş-Belinski Mohammad Doroudian
Daniela P. Foti Mona Boaz
Daniela Ribeiro Monica Rosa Loizzo
Daniele Bani Monika Kosmala
Daniele Contini Monika Łopuszańska-Dawid
Daniele Vergara Monika Modzelewska-Kapituła
Danielle Greenberg Mostafa Gouda
Daniil Olennikov Muhammad Ahsan Asghar
Darin Zerti Myoung-Sook Shin
Dario Di Silvestre Myron Szewczuk
Dario Siniscalco Nada Sallam
Dariusz Chlubek Nadezhda Golubkina
Dariusz Jedrejek Nae-Cherng Yang
David Aebisher Naroa Kajarabille
David Areshidze Natale Musso
David Greenhalgh Natalia Belosludtseva
David Lawrence Natalia Ivanovna Agalakova
David Leavesley Natalia Kurhaluk
Davide Bertelli Natalia Naumenko
Davide Di Paola Natércia Teixeira
Davide Giuseppe Ribaldone Nathalie Lalevée
Deborah Good Nathan K. Evanson
Deborah Penque Nathaniel Szewczyk
Deborah Verran Nayden Naydenov
Dejan Reljic Neeraj Chauhan
De-Li Shi Neli Olah
Delia Mezzanzanica Nemat Ali
Demetrios Arvanitis Nestor Gutiérrez-Méndez
Demin Cai Nevien Elhawat
Denis Silachev Nicholas Bradshaw
Denisa Margina Nihay Laham-Karam
Denise Schrama Nikhlesh Singh
Despina A. Tata Nikolaos Labrou
Diana Constantinescu-Aruxandei Nikolaos Nenadis
Diana Pinto Nikolay Brustovetsky
Diana Simona Antal Nima Sanadgol
Diego Franco Nina Kashchenko
Diego Romano Perinelli Niya Zhang
Dimitrios Galaris Norman Scott Litofsky
Dimitrios Stagos Noura Dosoky
Dimitris Kardassis Nukhet Aykin-Burns
Dimitris Makris Oana Pop
Dipak Kumar Sahoo Oksana Sherstneva
Dirk Montag Oleksii Skorokhod
Dirk W. Lachenmeier Olga Kopach
Ditta Ungor Olga Lyublinskaya
Dmitrii Mazhukin Olga Protchenko
Dmitriy Atochin Olga Redina
Dmitry Zorov Omar Cauli
Doaa Zineldeen Ondrej Vasicek
Dolores Hernanz Orlando Crescenzi
Domenico Ferro Ornella Maglio
Donald E. Spratt Oscar Briz Sanchez
Donghwa Kim Óscar Lorenzo González
Dong-Wook Han Othmane Merah
Dorota Formanowicz Otilia Ana Culicov
Dorota Olszewska-Słonina Ottmar Distl
Drago Beslo Ovidiu-Cristian Oprea
Edit Hermesz Pai Peng
Edson Da Silva Pamela Vignolini
Eduard Guasch Panagiotis Tassis
Eduardo Oliveira-Filho Pantelis Zebekakis
Edward N. Harris Paola Fini
Egor Plotnikov Paola Sangiorgio
Eiichi Kumamoto Paolo Arosio
Eirini Anastasaki Paolo Magni
Ekaterina Yurchenko Paolo Natale
Elena Donetti Paolo Paoli
Elena Falqué Paolo Silacci
Elena Grossini Pasquale Pagliaro
Elena Moretti Pasquale Scarcia
Elena Obrador Patrice X. Petit
Elena Sacco Patricia Wadowski
Eleni Mavrogonatou Patrick G. Arndt
Eleonore Fröhlich Patrick Martin
Elia Ranzato Patrick Poucheret
Eliana H. Akamine Paula Alexandra Lopes
Elio Pizzo Paula Daza Navarro
Elisa Cairrao Paula Silva
Elisabeth Pinart Paulo Gavaia
Elizabeth Fragopoulou Paulo J. Palma
Elke Pawelzik Paulo Netz
Elrashdy Redwan Paulo Santos
Elsa Chan Paulo Vale
Elsa Gonçalves Pavel Solopov
Elsayed Mansour Pedro Fernandes
Elżbieta Karlińska Pedro Ferreira-Santos
Elzbieta Salinska Pedro González-Redondo
Emiliano Bedini Petar Ozretić
Emiliano Martínez-Periñán Peter A. Roussos
Emilio Cervantes Peter C. Konturek
Emilio Viñuelas-Zahínos Peter Liddle
Emma Borrelli Péter Szentesi
Emmanouil Kalaitzakis Peter W. Physick-Sheard
Enric Gisbert Petko Alov
Enrico Moro Petras Prakas
Enrique Domínguez-Álvarez Petru Alexandru Vlaicu
Eric Hamlett Philip Chilibeck
Eric Huet Pierangelo Freschi
Erik Behringer Pierluigi Stipa
Erik Klein Piero Sestili
Erxi Wu Pierre Tennstedt
Esmat Ali Pietro Scicchitano
Estelle Léonard Ping-Chung Kuo
Esther Ocola Piotr B. Heczko
Estibaliz Sansinenea Piotr Latocha
Eugene Rogozhin Piotr Michel
Eugenio Ragazzi Piotr Sugier
Eva Santos Piotr Szymczyk
Evangelia Antoniou Premranjan Kumar
Evangelia Maria Tsapakis Pu Zheng
Evangelia Sarantopoulou Pushpa Joshi
Evgenia Sitnikova Qasim Alhadidi
Ewa Jakubczyk Qi Xiang
Ewa M. Kalemba Qibin Yu
Ewa Tomaszewska Quan Nguyen Van
Fabienne Lamballe Rachel Nadif
Fábio Seiva Radoslaw Podsiadly
Fabrizio Damiano Radoslaw Starosta
Fabrizio Martora Radu Claudiu Fierascu
Facultad Farmacia Radu Sestras
Fadia Youssef Rafael Coveñas Rodríguez
Federica Blando Rafael Guillen
Felix Clanchy Rafael Salto
Feng-Qing Yang Rafał Frański
Fernanda Vilarinho Rafal Ziobro
Fernando Ferreira Raffaele Serra
Fernando Monroy Raffaella Rossi
Filippo Torrisi Ralf Blank
Filomena Monica Vella Ram Babu Undi
Flaminia Vena Ramkumar Kunka Mohanram
Fleurat-Lessard Paul Ramya Tokala
Florence Carrouel Ranjit De
Fong-Yu Cheng Raquel Bridi
Francesca Silvagno Raquel Sousa
Francesco Balestri Ravi Sonani
Francesco Ciccarese Renata Bączek-Kwinta
Francesco Maria Calabrese Renata Walczak-Jędrzejowska
Francesco Oriente Renato Xavier Coelho Dos Santos
Francesco Serrapica René Huber
Francesco Sessa Reza Mortazavi
Francisco A. Arrebola Rhitajit Sarkar
Francisco Dasí Ricardo Alcántara-De La Cruz
Francisco Espinosa Ricardo Ruiz-Villaverde
Francisco Garcia-Canovas Riccardo Amorati
Francisco García‐Cozar Riccardo Nevola
Francisco Guillen-Grima Richard Drevet
Francisco Javier Silvestre Richard Naftalin
Francisco José Minero Riikka Martikainen
Francisco Lázaro-Diéguez Rita Payan-Carreira
Francisco Marco Rita Rezzani
Francisco Miguel Martínez-Arnau Rob Hoeben
Francisco Pradas De La Fuente Robert Ancuceanu
Franciska Erdő Robert Kleszcz
Frank Vriesekoop Robert L. Meisel
Franko Burcul Robert Newman
Franz Zehentmayr Robert Tyler
Fulvia Farabegoli Roberta Imperatore
Gabi Drochioiu Roberta Moschini
Gábor Kökény Roberto Ciccoritti
Gabriel Marc Roberto Codella
Gabriele Grunig Roberto Lemus-Mondaca
Gabriel-Ionut Plavan Rocio Gil-Muñoz
Gaetano Santulli Roger Clemens
Gáspárdy András Rolf Heumann
Gavino Sanna Roman Irgashev
Gederts Ievinsh Ronaldo Thomatieli-Santos
Geert Potters Ronan Murphy
Gema Navarrete Rosa María Giráldez-Pérez
Gemma Palazzolo Rosa Suades
George-Albert Karikas Rosa Vona
Georgios Pampalakis Rosalba Senese
Georgios Papadopoulos Rosanna Mallamaci
Geraldine Gueron Rosanna Squitti
Gerardo Barbero Rosaria Meccariello
Gergő Tóth Rosaria Varì
Gerhild Euler Rui Borges Dos Santos
Giampiero Cai Rui F. M. Silva
Gian Luigi Russo Rui M. S. Cruz
Gianluca Rizzo Rui Vitorino
Gilles Lemaître Rumyana Simeonova
Gina-Cecilia Pistol Runze Li
Giorgia Sarais Rusan Catar
Giorgia Sollai Ryota Hosomi
Giorgio Lenaz Sabina Galiniak
Giovanna Romano Sabrina Oliva
Giovanni Casini Sagrario Martín-Aragón
Giovanni Levi Sajal Sen
Giovanni Mario Pes Salvador Ruiz
Giovanni Mita Sanda Andrei
Giovanni Pallio Sándor Beszédes
Giovanni Ribaudo Sandra Cabo Verde
Girish Srivastava Sandra Donnini
Gisela Beutner Sandra Ghelardoni
Giulia Ricci Sanjay Gupta
Giuliana Muzio Sankar Jagadeeshan
Giulio Fortuna Santa Cirmi
Giuseppe Cirillo Santiago Pedro Aubourg Martínez
Giuseppe Malfa Sascha Rohn
Giuseppe Martino Satyesh K. Sinha
Giuseppina Amadoro Sebastian Schwaminger
Gjin Ndrepepa Sebastiano Cicco
Glenn P. Dorsam Selvakumar Subbian
Gloria Salazar Seon-Yong Jeong
Goran Baranović Serena Del Turco
Goran Gajski Serena Reggi
Graziella Tocco Sergei Boichuk
Grażyna Neunert Sergei Gaidin
Grażyna Nowicka Sergey Dikalov
Gregorio Peron Sergey Sedykh
Greta Krešić Sergio Minucci
Grzegorz Bartosz Sergio Recalde
Grzegorz Cieślar Serkos Haroutounian
Grzegorz Grześk Seungrock Lee
Guanglin Zhang Seyed Khosrow Tayebati
Guglielmina Froldi Shalini Dogra
Guglielmo Duranti Shane Thomas
Guillermo Cásedas Shanmuga S. Mahalingam
Guillermo López-Lluch Shaobin Wang
Guillermo Martínez-Ávila Shaohua Wang
Guillermo Tellez Shao-Ming Wang
Gundula Schulze-Tanzil Sharad Purohit
Guzel Ziyatdinova Shereen Basiouni
Haijun Liu Shiho Ohnishi
Haike Antelmann Shin-Ichi Kayano
Hailong Hu Shu-Cheng Huang
Haim Breitbart Silvano Dragonieri
Haiquan Liu Silvia Arribas
Hakim Manghwar Silvia Berto
Hamed Nosrati Silvia Dossena
Hammad Ullah Silvia Finnemann
Hana Rauchová Silvia Mironeasa
Hanna Kowalska Simona Dedoni
Hanna Szaefer Simona Lucioli
Hanns Moshammer Simona Mirel
Hans Bäumler Simone Landi
Hans-Petter Hersleth Sinian Char
Hanying Chen Sladjan Pavlovic
Harald Schulze Sławomir Borek
Haruki Usuda Snježana Kaštelan
Haya Lorberboum-Galski Sofia R. Pauleta
Hayato Terayama Sonia Benítez
Hector Melendez-Ortiz Søren Christensen
Héctor Quezada Sotiria Vrouva
Hedvig Fébel Sotirios Kalfas
Hee Kyoung Joo Sotirios N. Kiokias
Heiko Sorg Spiros Paramithiotis
Hengyi Xu Stanisław Kalisz
Herbert Ryan Marini Stanisław Kowalski
Hideo Wada Stanislaw Ołdziej
Hiroaki Inaba Stefania Garzoli
Hiroyuki Wakiguchi Stefano Bacci
Ho-Jin Lee Stefano Casalotti
Holger Herff Stefano Fumagalli
Holger Steinbrenner Stefano Giannubilo
Hongbing Fan Stefano Lettieri
Hsing-Hui Li Stefano Piazza
Hsinjung Ho Stefano Pieretti
Hsiu-Mei Chiang Stefano Vendrame
Hsiuying Wang Steffen Maak
Huaiwei Liu Stephan Wildeus
Huang Li Stephen Inbaraj
Hubert Sytykiewicz Steven Esworthy
Hugo Espinosa Andrews Sung Gu Han
Huining Kang Sushanta Saha
Hung-Chi Cheng Suzanne De La Monte
Hung-Pin Tu Sveinung Sorbye
Hyuck Jin Lee Sven Sängerlaub
Hyung Sik Kim Svetlana Simova
Hyun-Jae Shin Svetoslav Todorov
Hyun-Ouk Kim Swarup Roy
Iain Brownlee Swati More
Ignacija Vlašić Syed Husain Mustafa Rizvi
Ignacio Badiola Sylwester Czaplicki
Ignacio Rodríguez-García Sylwia Zielinska
Igor Turkiewicz Taesun Min
Ilaria Bellezza Taiki Miyazawa
Ilaria Cacciotti Takashi Ishino
Ilaria Campesi Takashi Kumagai
Ilaria Zanotti Takashi Yazawa
Ilavenil Soundharrajan Takemichi Fukasawa
Ildiko Szanto Takuji Ohyama
Ileana Farcasanu Takujiro Homma
Ilias Giannenas Takumi Abe
Imran Ali Khan Talha Bin Emran
In Koo Hwang Tamás Hofmann
Ines Aguinaga-Ontoso Tamas Kalai
Ines Drenjancevic Tao Chen
Ines Mancini Tatijana Zemunik
Inga Kwiecien Tatsuo Kanda
Ioannis Anestopoulos Tatsuro Mutoh
Ioannis Kanakis Teleky Bernadette-Emoke
Ioannis-Dimosthenis Adamakis Teresa Semedo-Lemsaddek
Irena Nalepa Teresa Zoladek
Irena Wojsyk-Banaszak Thibaud Coradin
Irene Caffa Thierry Cens
Irene Dini Thomas Crenshaw
Irene Lorrai Thomas Greither
Irene Rosa Thomas Van Groen
Irene Valasi Tianhua Niu
Irina Milisav Timur Mirzoev
Irina Petrushanko Tiziana Bachetti
Isaac Sundar Tom Broderick
Isabel Marques Tomáš Čajka
Isabel P. Fernandes Tomas Rousar
Isabella Panfoli Tomasz Frączyk
Isac Medeiros Tomasz Szablewski
Isao Yumoto Tomomi Yamazaki
Ismael Cross Triantafyllos Didangelos
Istvan Lekli Trish Berger
Istvan Zupko Tsunahiko Hirano
Ítala Marx Tsung-Cheng Tsai
Iuliana Aprodu Tsuyoshi Yoda
Ivan Savic Tuba Esatbeyoglu
Ivana Škrlec Tudor Borza
Iveta Bernatova Tusty-Jiuan Hsieh
Iwona Jarocka-Karpowicz Tyler Lebaron
Iza Peréz-Ramírez Uener Kolukisaoglu
J. Basilio Heredia Ulrich Gergs
Jacco Briede Ulrike Resch
Jacek Zielonka Ungureanu-Iuga Mădălina
Jacopo Junio Valerio Branca Urmi Roy
Jacqueline Leite Uwe Rudolph
Jacqueline Takahashi Vadim Volkov
Jadwiga Hamulka Valentina Dini
Jae-Hyung Park Valentina Melini
Jaime Romero Valentina Passeri
Jakub Rok Valentina Vellecco
James Chow Valentine Usongo
James D. West Valeria Sogos
Jan Bocianowski Valerie Carabetta
Janeen Salak-Johnson Valery Bochkov
Janos Filep Vanja Travičić
Janosch P. Heller Vassilia Sinanoglou
Janusz Madaj Vassilios Dotas
Jarosław Czyż Vassilis Athanasiadis
Jarosław Przybył Vassya Stefanova Bankova
Javier Lopez Vehary Sakanyan
Javier Martinez-Useros Venera Cardile
Javier Rodriguez Carpena Venkateswarlu Kanamarlapudi
Jayanta Kumar Patra Verena Tretter
Jean Daniel Coisson Veronica Marrella
Jean Regal Veronika Hyskova
Jean Vanderpas Vicente Martí-Centelles
Jean-Baptiste Renard Victor Quesada
Jeffrey Brault Victor Seledtsov
Jelena Popović-Djordjević Vigneshwaran Vellingiri
Jennifer Gubitosa Vincent C. Lombardi
Jeong Yeon Kim Vincenzo Micale
Jérémy Couturier Vincenzo Piccolo
Jer-Ming Chang Vincenzo Summa
Jerzy Juskiewicz Vincenzo Tufarelli
Jesús Pastor Violetta Macioszek
Jiafen Hu Virginie Monnet-Corti
Jiangnan Peng Visnja Stepanic
Jianzhu Liu Vladimir Dvoretsky
Jinghua Wang Vladimir Ivanov
Jingjing Tang Vladimir Kalinin
Joachim F. Greilberger Vladimir Tikhonov
João Henrique Ghilardi Lago Vojko Kanic
João Pedro Silva Waldo Cerpa
Joao Pessoa Wanda Mączka
João Simões Wei Guo
Joaquim C. G. Esteves Da Silva Wei-Hsiung Yang
Jochen D. Schipke Wei-Min Chen
Jochen G. Schneider Wei-Ning Lin
Joel Drevet Wenchao Xu
Johannes De Bruijn Wen-Hsi Cheng
John Carragher Wesley Raup-Konsavage
John Parrish William N. Setzer
John Sinclair Willibald Wonisch
Jolán Csiszár Wi-Young So
Jolanta Dlugaszewska Wolfram Kunz
Jolanta Sereikaite Wupeng Liao
Jordi Bover Xiaohu Zhao
Jorge Santos Xiaohua Teng
José Artur Brito Xiao-Ming Sun
José Carlos Menéndez Xinyu Wang
José Catita Yan-Ming Xu
José David Flores-Félix Yasukazu Nakahata
José Justicia Yasumasa Okazaki
José Leitão Yiannis Kourkoutas
Jose Miguel-Hidalgo Yin Zhao
Jose Mulet Ying-Ming Liou
José Pedraza-Chaverri Yitao Qi
José Pinela Yixi Xie
José Ramiro Fernandes Yolande T. R. Proroga
Josiana Vaz Yongsheng Chen
Josko Bozic Yong-Xin Liu
Jozsef Dudas Yorito Hattori
Juan Corbera Yoshihiro Shidoji
Juan Guzman-Flores Yoshika Sekine
Juan Ignacio Vilchez Yoshikane Yamauchi
Juan Leon Yoshinori Katakura
Juan Mozas-Moreno Young-Whan Choi
Juan R. Muñoz-Castañeda Youssef Rouphael
Juan-Carlos Galvez-Ruiz Yu Zhou
Judit Doczi Yu-Chin Lien
Judit Oláh Yue Yang
Judith Klein-Seetharaman Yuet-Kin Leung
Julio Figueroa Yuh-Shuen Chen
Julio Ochoa Yung-Hsiang Chen
Jun Liu Yusheng Liang
Junchao Tong Yutang Wang
Junichi Inaba Yuya Kumagai
Jun-Ichiro Jo Yuyan Jiang
Junzi Wu Yves Combarnous
Ka Fai William Tse Zaida Abad-Jiménez
Kabirullah Lutfy Zapryana Denkova
Kacper Nijakowski Zdeněk Fišar
Kandi Sridhar Zhen Chen
Karel Allegaert Zhengwei Huang
Karen Khachatryan Zhenyu Zhang
Karola Vorauer-Uhl Zhichuan Zhu
Karolina A. Wojtunik-Kulesza Zofia Mazerska
Karolina Szewczyk-Golec Zoltán Kukor
Karsten Grote Zong Jie Cui
Katalin Sipos Zoran Todorovic
Katarzyna Dudek Zuohui Zhang
Katarzyna Komosinska-Vassev Zygmunt Warzecha
Katarzyna Krukiewicz

Back to TopTop